07/11/2019 – AB Science announces positive top-line phase 3 results for oral masitinib in severe asthma
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
07/11/2019 – AB Science announces positive top-line phase 3 results for oral masitinib in severe asthma